PPLPHARMA vs M&MFIN: Stock Comparison
Head-to-head financial and trading comparison between Piramal Pharma Limited (PPLPHARMA) and Mahindra & Mahindra Financial Services Limited (M&MFIN) in the Cross-Sector Peers sector.
PPLPHARMA
NSE: PPLPHARMAM&MFIN
NSE: M&MFINKey Metrics Comparison Table
| Metric | PPLPHARMA | M&MFIN | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹196.88 | ₹319.45 | — |
| 1-Year Price Return | +32.32% | +5.22% | PPLPHARMA (27.10% higher) |
| 52-Week High | ₹226.62 | ₹412.30 | — |
| 52-Week Low | ₹148.79 | ₹275.70 | — |
| 30-Day Annualized Volatility | 32.84% | 26.44% | M&MFIN (Steadier) |
| 30-Day Average Daily Volume | 3,775,308 | 1,848,112 | PPLPHARMA (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between PPLPHARMA and M&MFIN, which stock gave better returns over the last year?
PPLPHARMA has outperformed M&MFIN over the past 12 months with a gain of 32.32% compared to 5.22%.
Which stock is less volatile: PPLPHARMA or M&MFIN?
M&MFIN demonstrated lower price volatility (26.44% annualized) compared to PPLPHARMA (32.84%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of PPLPHARMA vs M&MFIN?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are PPLPHARMA and M&MFIN direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.